کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5633471 1406576 2017 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Original articleDescriptive study of the parkinsonian population in the north of France: Epidemiological analysis and healthcare consumption
ترجمه فارسی عنوان
مقاله اصلی مطالعه توصیفی جمعیت پارکینسونی در شمال فرانسه: تجزیه و تحلیل اپیدمیولوژیک و مصرف مراقبت های بهداشتی
کلمات کلیدی
بیماری پارکینسون، همهگیرشناسی، شیوع، بازپرداخت صندوق بیمه، مصرف مراقبت،
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی عصب شناسی
چکیده انگلیسی

BackgroundThe “neurodegenerative diseases plan” under elaboration for the Hauts-de-France region requires better knowledge of the patient population and care pathways. In France, the prevalence of Parkinson's disease (PD) has been estimated from cohorts to be about 1-3 per 1000 inhabitants, but exhaustive data are scarce for the general population. The purpose of this study was to evaluate the prevalence of PD in the Hauts-de-France region and to assess PD-related healthcare consumption.MethodA descriptive study was conducted to identify the parkinsonian population in the Hauts-de-France region (including the administrative districts of Pas-de-Calais and Picardie) for the year 2014. Parkinsonian patients were identified from health insurance fund reimbursement data using the following criteria: (i) reimbursement for a PD-specific medication; (ii) attribution of long-duration disease status coded as PD; (iii) hospital stay with PD diagnosis in the standard discharge report contained in the French medico-economic database on hospital activity (PMSI).ResultsThe raw prevalence of PD in the region was 5.03 per 1000 inhabitants aged 20 years and older. The standardized prevalence by health territory ranged from 4.0 to 9.0 per 1000 inhabitants aged 20 years and older. During the 1-year study period, 33.5% of patients had a neurology consultation, 57.1% attended a physiotherapy session, and 7.7% received speech therapy. Most of patients (79.6%) were treated with levodopa, sometimes in combination with a catechol-O-methyl transferase inhibitor (14.4%). Dopaminergic agonists were prescribed in 33.5% of cases. A neuroleptic was prescribed for 6.9% of the population (clozapine for 25.9%).ConclusionThe prevalence of PD is high in the Hauts-de-France region with a heterogeneous distribution by health territory. Neurology consultations were attended by a minority of patients in 2014. This work provides perspectives for necessary improvement in specialized care for this disease, both in terms of follow-up consultations and home care.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Revue Neurologique - Volume 173, Issue 6, June 2017, Pages 396-405
نویسندگان
, , , , , , , , ,